Semaglutide and Tirzepatide: Exploring Brand and Compounded Options at Body Good Studio
The landscape for diabetes and obesity treatment has evolved with GLP-1 receptor agonists like Semaglutide and Tirzepatide. At Body Good Studio, we offer both brand and compounded versions of these medications, giving our patients a choice based on their individual needs.
Brand GLP-1 Medications: Semaglutide and Tirzepatide
Pros:
• FDA Approval: Ensures efficacy, safety, and quality.
• Consistent Manufacturing: Guarantees potency and purity.
• Research-Backed: Supported by extensive clinical evidence.
• Insurance Coverage: Likely to be covered, with prior authorization.
Cons:
• Cost: Ranges from $25 with insurance coverage to $500-$800 with a manufacturer coupon, up to $1500 out-of-pocket.
• Insurance Limitations: Restrictions or high copays.
• Fixed Formulations: Less flexibility compared to compounded medications.
Compounded GLP-1 Medications: A Customized Approach at Body Good Studio
Pros:
• Customization: Personalized dosages and formulations.
• Cost-Effective: Semaglutide at $275 and Tirzepatide at $375.
• Accessibility: Suitable for those without comprehensive insurance coverage.
Cons:
• Lack of FDA Approval: Raises questions about efficacy and safety.
• Inconsistency: Variability in manufacturing.
• Limited Research: Less clinical data available.
• Insurance Coverage: Often not covered by insurance plans.
At Body Good Studio, we prioritize safety and quality. We collaborate only with compound pharmacies that adhere to high industry standards and regulations, including those set by bodies like the U.S. Pharmacopeia (USP) and the Pharmacy Compounding Accreditation Board (PCAB). Our commitment to safety and adherence to regulations ensures the highest quality in compounded medication options.
Conclusion: Tailored Treatment Options at Body Good Studio
Choosing the right GLP-1 medication — whether a brand name like Semaglutide and Tirzepatide or a compounded version — is a decision that should be made with careful consideration. At Body Good Studio, we offer both options to meet the diverse needs of our patients. Book a consultation with us to learn more about which option is best for you and discover a path to better health and wellness.
Keep reading

Maximizing Access to Semaglutide/Tirzepatide: A Guide to Pharmaceutical Coupons and Prior Authorization
<span data-mce-fragment="1">This guide aims to simplify the use of pharmaceutical coupons and the prior authorization process, ensuring our patients can access these vital medications.</span>
Oral Maintenance Options After GLP-1s
Transitioning off GLP-1 medications doesn't mean your progress has to stop. Learn about oral maintenance options that may help support healthy weight management and long-term success with Body Good Studio.
Maintenance Dosing vs Stopping GLP-1s: Which Is Right for You?
Should you continue maintenance dosing or stop GLP-1 treatment after reaching your weight goals? This blog explores the benefits, risks, and key factors to help you choose the best long-term approach with guidance from Body Good Studio.
What Causes Regain and How to Prevent It
Weight regain can happen for many reasons, from metabolic changes to lifestyle habits after losing weight. This blog explains the common causes and shares practical, science-backed strategies to help maintain long-term results with Body Good Studio.
Stopping GLP-1s and Keeping Weight Off: Step-Down Plans, Maintenance Dosing, and Metabolic Support
Stopping GLP-1 medications does not have to mean regaining weight. This blog explores effective step-down strategies, maintenance dosing options, and metabolic support solutions that can help sustain long-term weight loss results. Learn how lifestyle habits, targeted supplements, and wellness injections may support metabolism, appetite control, and overall wellness after GLP-1 treatment. Discover practical approaches to maintaining your progress and achieving lasting weight management success.
Does Medicare Cover Semaglutide? What You Need to Know
Medicare Part D doesn't cover weight loss medications — but there are exceptions, workarounds, and alternative pathways. Here's what actually works in 2024.
